Lab Testing Clause Samples

Lab Testing. Verily will be responsible for contracting with a laboratory to conduct all testing of samples collected through the Program (the “Testing Lab”). If Verily determines that an alternative approach to laboratory testing has become feasible during the course of the Program, Verily will notify State, CDPH, and/or the applicable Counties and the parties will collaborate in good faith to adjust the workflow and third party contracting, as appropriate, to accommodate the new approach.

Lab Testing. With respect to Laboratory Testing, Supplier shall comply with the separate Lab Testing Agreement executed by the parties.

Lab Testing. Vendor’s testing methodologies have all been determined by the Center for Disease Control and Prevention (“CDC”) and U.S. Food and Drug Administration (“FDA”) to be acceptable emergency use authorized tests. Vendor performs molecular COVID-19 tests and uses the “short swab” technique. Vendor will only use nasopharyngeal or nasal swabs collection techniques employed in the anterior nares. Vendor will perform all COVID-19 PCR testing for CPS at its Elmwood Park, New Jersey location. Vendor’s other laboratory locations will serve as backup laboratories if and when Elmwood Park is unable to process specimens. The specimens will be collected at the school or facility locations selected by CPS and then transported to Vendor’s laboratory locations where they will be accessioned and then tested on one of Vendor’s Emergency Use Authorization (“EUA”) FDA authorized instruments. All test specimens will be transported by Vendor to its labs in a temperature regulated environment. Vendor will continue to look at all emerging technologies and adapt testing to the needs of the patients and communities. If a new technology emerges that the Board and Vendor agrees is a more effective testing technology, Vendor will agree to utilize that technology if directed to do so by the Board. Vendor uses FDA EUA platforms for real time RT-PCR testing for COVID-19. Real time RT- PCR Testing is a nuclear-derived method for detecting the presence of specific genetic material in any pathogen. Vendor has utilized the following four platforms: 1) Roche assay: COBAS 8800 2) ThermoFisher assay: APPLIED BIOSYSTEMS 7500 FAST DX and THERMOFISHER QUANT12KFLEX 3) Hologic assay: PANTHER FUSION 4) Seegene assay: BIO-RAD CFX96 Under the Program, Vendor will comply with all applicable standards under the Clinical Laboratory Improvement Amendments of 1988 (“CLIA”) and College of American Pathologists. Vendor further operates a CLIA-certified laboratory, where it runs its PCR tests and can report results back to the individual and CPS within 48 hours of receiving the test sample. Vendor’s lab has the capacity to process a minimum of ten thousand (10,000) tests weekly for CPS. Vendor’s lab also has the capability to process larger test numbers in the event that CPS expands the Program. If Vendor cannot analyze a specimen because of improper collection or degradation in process, or is unable to obtain satisfactory test results, Vendor will notify Board and arrange for any resampling necessary. In the even...

Lab Testing. Subject always to the best interests of the patients of the Clinic and to any applicable professional or legal restrictions, ______________ shall make use of such laboratory facilities for testing and other purposes as may be specified from time to time by the Clinic.

Lab Testing. Company shall cooperate with Distributor for the rebottling aging test. The Distributor will be responsible for sending samples using Fedex to Company for testing. Company shall provide test reports back to Distributor.

Lab Testing. Soil samples recovered by the geologist during the geo-technical investigation will be taken to Ninyo & Moore’s laboratory, where testing shall be completed to address index soil characteristics for both soil classification and correlation with soil mechanical characteristics (i.e., strength and compressibility).